(SENS) Senseonics Holdings - Ratings and Ratios

Exchange: NYSE MKT • Country: United States • Currency: USD • Type: Common Stock • ISIN: US81727U1051

SENS: Eversense, Eversense XL, Eversense E3

Senseonics Holdings, Inc., a medical technology company, specializes in the development and manufacturing of continuous glucose monitoring (CGM) systems designed to improve diabetes management. The companys flagship products, Eversense, Eversense XL, and Eversense E3, are implantable CGM systems that measure glucose levels through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a user-friendly app for real-time monitoring and data management. These systems are differentiated by their extended wear times, with Eversense XL offering up to 180 days of continuous use, and Eversense E3 designed for 60 days, catering to different patient preferences and clinical needs.

Founded in 1996 and headquartered in Germantown, Maryland, Senseonics has established itself as a pioneer in the CGM space, particularly with its focus on implantable technology. The company distributes its products through a network of healthcare providers, distributors, and strategic partners, ensuring access to patients globally. Senseonics technology integrates advanced sensor design, proprietary fluorescence-based chemistry, and mobile health software, providing users with accurate and reliable glucose data to manage their diabetes effectively.

Ticker Symbol: SENS Exchange: NYSE MKT Type: common stock Country Origin: United States GICS Sub Industry: Health Care Supplies

Average Volume 20d: 9,866,596 Last Price: 0.83 SMA 20: 1.02 SMA 50: 0.81 SMA 200: 0.49 ATR: 0.12

Market Cap: 495.31M USD P/E: 0.00 P/E Forward: 21.51 P/B: 340.53 P/S: 22.31 RoE: 467.55

3-Month Forecast: Based on , SENS is currently trading below its 20-day and 50-day SMA, indicating bearish momentum in the short term. The stocks ATR of 0.12 suggests moderate volatility, with potential downside targets at $0.60 and $0.40 if the downtrend continues. However, if the stock rebounds off support levels, a potential upside target of $1.20 could be achievable. From a perspective, the companys high P/B ratio of 340.53 raises concerns about valuations, while the forward P/E of 21.51 reflects expectations of future profitability. The companys ability to improve margins and reduce operating losses will be critical in the near term.

Additional Sources for SENS Stock

SENS Stock Overview

Market Cap in USD 400m
Sector Healthcare
Industry Medical Devices
GiC Sub-Industry Health Care Supplies
IPO / Inception 2016-03-17

SENS Stock Ratings

Growth 5y -15.0%
Fundamental -19.9%
Dividend 0.0%
Rel. Strength Industry 5.08
Analysts 3.25/5
Fair Price Momentum 0.56 USD
Fair Price DCF -

SENS Dividends

No Dividends Paid

SENS Growth Ratios

Growth Correlation 3m 50.6%
Growth Correlation 12m 9.9%
Growth Correlation 5y -33.2%
CAGR 5y -3.53%
CAGR/Max DD 5y -0.04
Sharpe Ratio 12m -1.16
Alpha -13.19
Beta 2.31
Volatility 123.32%
Current Volume 2706.3k
Average Volume 20d 7443.9k
What is the price of SENS stocks?
As of March 16, 2025, the stock is trading at USD 0.59 with a total of 2,706,263 shares traded.
Over the past week, the price has changed by -8.26%, over one month by -52.17%, over three months by +34.61% and over the past year by +6.01%.
Is Senseonics Holdings a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Senseonics Holdings is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -19.93 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SENS as of March 2025 is 0.56. This means that SENS is currently overvalued and has a potential downside of -5.08%.
Is SENS a buy, sell or hold?
Senseonics Holdings has received a consensus analysts rating of 3.25. Therefor, it is recommend to hold SENS.
  • Strong Buy: 1
  • Buy: 1
  • Hold: 1
  • Sell: 0
  • Strong Sell: 1
What are the forecast for SENS stock price target?
According to ValueRays Forecast Model, SENS Senseonics Holdings will be worth about 0.6 in March 2026. The stock is currently trading at 0.59. This means that the stock has a potential upside of +8.47%.
Issuer Forecast Upside
Wallstreet Target Price 1.6 171.2%
Analysts Target Price 2.3 281.4%
ValueRay Target Price 0.6 8.5%